Why AFib causes strokes
Last reviewed November 17, 2026. OwieClear editorial team. Waiting for clinician review. Not medical advice. Talk with your doctor about your own care.
The link between a quivering heart chamber and a damaged brain runs through one small pouch and one piece of plumbing. Understanding it explains why anticoagulants are the first thing discussed.
It also explains why these strokes tend to be larger than average, and why prevention matters more than reaction.
Related pages: Atrial fibrillation (AFib)
The bottom line
- Clots form mainly in the left atrial appendage, where blood pools.
- A clot that breaks off travels to the brain in most cases.
- AFib-related strokes tend to be larger and more disabling than average.
- Anticoagulants substantially reduce this risk; aspirin does not do the job.
- Risk is estimated from risk factors, not from symptoms or episode frequency.
- Why some low-risk people still have strokes.
- How much residual risk remains after successful ablation.
- How to personalise risk beyond the standard scores.
The story, step by step
What the evidence labels mean
Where the clot forms
What happens
A blind alley in the left atrium.
What the research shows
- The left atrial appendage is a narrow, finger-shaped pouch off the left atrium, a remnant of how the heart forms before birth.
- In normal rhythm, atrial contraction flushes it out with each beat.
- In AFib there is no contraction, so blood in the pouch barely moves. Its shape means there is no through-flow to clear it.
- Stagnant blood, a lining that becomes inflamed and dysfunctional, and shifts in clotting proteins together make clotting likely. These three together are the classic conditions for thrombosis.
- The large majority of clots found in AFib are in this pouch.
- That is why it can be closed off with a device or surgically removed in people who cannot take anticoagulants.
Why it matters
A single anatomical cul-de-sac explains most of the stroke risk in AFib, and it is why treatment can be aimed so specifically.
What's still uncertain
- How much appendage shape and size change individual risk.
- How closure devices compare with long-term anticoagulants.
Read more
- NHLBI: Atrial fibrillationGovernment
- MedlinePlus: StrokeGovernment
- American Heart Association: atrial fibrillationNonprofit
Next: The journey
Why it goes to the brain
What happens
Plumbing, not bad luck.
What the research shows
- A clot leaving the left atrium passes into the left ventricle and out through the aorta, the body's main artery.
- The first large branches off the aorta supply the head and neck, and the brain receives a large share of total blood flow.
- So a clot from the left side of the heart reaches the brain more often than anywhere else, though it can also lodge in a limb, the gut, a kidney or the eye.
- A clot blocking a brain artery cuts blood flow, and brain tissue downstream begins dying within minutes. That is an ischemic stroke.
- Blockage of a smaller branch may cause a transient ischemic attack, with symptoms that resolve. That is a warning, not a false alarm, and needs urgent assessment.
- The key point is that the stroke happens far from the problem, with no warning from the heart itself.
Why it matters
Nothing about how the heart feels predicts this event, which is why prevention cannot be guided by symptoms.
What's still uncertain
- Why clots lodge where they do.
- How often silent brain injury occurs in AFib.
Read more
- MedlinePlus: StrokeGovernment
- CDC: StrokeGovernment
- NHLBI: StrokeGovernment
Next: Why they are severe
Bigger clots, bigger strokes
What happens
Cardioembolic strokes tend to be larger.
What the research shows
- Clots formed in a large, slow-moving chamber are typically bigger than those formed in a narrowed artery.
- A bigger clot blocks a bigger artery, so more brain is affected at once.
- Strokes related to AFib are, on average, more disabling and carry higher mortality than strokes from other causes.
- They also happen without warning. Narrowed arteries sometimes announce themselves; a clot from the atrium does not.
- AFib is also associated with silent brain injury and with a higher risk of cognitive decline over time, even without an obvious stroke.
- Roughly one in five to one in four ischemic strokes is attributed to AFib, and a share of those occur in people whose AFib was not yet known about.
Why it matters
The severity of the average AFib stroke is the main reason the risk-benefit calculation favours anticoagulation for most people with meaningful risk factors.
What's still uncertain
- How much of the cognitive decline is from silent infarcts.
- Whether treating AFib earlier protects cognition.
Read more
- American Stroke AssociationNonprofit
- NHLBI: StrokeGovernment
- MedlinePlus: StrokeGovernment
Next: What reduces it
Anticoagulants, and not aspirin
What happens
The intervention with the biggest effect.
What the research shows
- Oral anticoagulants substantially reduce the risk of stroke in AFib. This is one of the better-established benefits in cardiology.
- Direct oral anticoagulants, such as apixaban, rivaroxaban, edoxaban and dabigatran, are first-line for most people. Warfarin remains the right drug in specific situations, including mechanical heart valves and some mitral valve disease.
- Aspirin is substantially less effective for this purpose and is no longer recommended as a substitute in people who need anticoagulation.
- The decision is individualised by weighing stroke risk factors against bleeding risk, using a score as a starting point rather than a verdict.
- Controlling the rhythm does not remove the need for anticoagulation in people at risk, and neither does a successful ablation in most cases.
- Stopping anticoagulation without medical advice is one of the highest-risk things a person with AFib can do.
Why it matters
The most consequential conversation in AFib care is about this one class of medicine, and it is worth going into properly rather than accepting or refusing it quickly.
What's still uncertain
- How long anticoagulation should continue after successful ablation.
- How to manage people at high risk of both stroke and bleeding.
Read more
- MedlinePlus: Blood thinnersGovernment
- NHLBI: Atrial fibrillationGovernment
- American Heart Association: atrial fibrillationNonprofit